Recurring Mistakes (And Remedies) For Life Sciences M&A
Life science management teams fall victim to recurring mistakes and entrapments. This article discusses avoidable missteps in M&A transactions and their respective remedies.
Recurring Mistakes (And Remedies) For Life Sciences M&A
Published in Life Science Leader, January 2018
Authors: Dr. Oded Ben-Joseph and Thomas Busby
As members of a specialized life sciences investment banking group focused on private equity financing and M&A, we often note that life science management teams fall victim to recurring mistakes and entrapments. Below is a list of avoidable missteps in M&A transactions and their respective remedies.
Federal Data Systems Has Received an Investment from McNally Capital
Federal Data Systems Has Received an Investment from McNally Capital August 30, 2018, Reston, VA Federal Data Systems, Inc (FedData) has received an investment from McNally Capital. FedData is a leader in providing critical infrastructure and services to the Department of Defense and the National Intelligence Community, and a provider of threat reduction and counterintelligence […]
Read MoreNews
Outcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group
Outcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group June 18, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that serves middle market growth companies in the life science and technology segments, is pleased to announce that its client, Digital Intelligence Systems (DISYS), a global staffing and IT consulting firm, […]
Read MoreContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2018. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Business Continuity Plan | Privacy Policy
